We are live on ! Find out more
CPX

Canaan Partners X Portfolio holdings

AUM $74.7M
1-Year Est. Return 151.56%
This Fund
S&P 500
This Quarter Est. Return
+87.69%
1 Year Est. Return
+151.56%
3 Year Est. Return
+55.41%
5 Year Est. Return
10 Year Est. Return
AUM
$83.4M
AUM Growth
-$7.49M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXTC icon
1
NextCure
NXTC
$20.8M
$43.5M 52.17%
169,037
IDYA icon
2
IDEAYA Biosciences
IDYA
$3.54B
$37.8M 45.36%
2,660,713
ITRM
3
DELISTED
Iterum Therapeutics
ITRM
$2.06M 2.47%
115,545

Similar funds

Canaan Partners X's Q2 2020 Portfolio in Review

As of Q2 2020, Canaan Partners X held 3 positions worth $83.4M, down 8.2% from $90.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 0%. Canaan Partners X opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Canaan Partners X's ten largest holdings make up 100% of its $83.4M portfolio in Q2 2020.
  • Canaan Partners X opened 0 new positions and closed 0 in Q2 2020.
  • Canaan Partners X's portfolio value fell 8.2% quarter-over-quarter to $83.4M.

Based on Canaan Partners X's 13F filing for Q2 2020, filed 10 Aug 2020.